Schoenberg Mark sold URGN
August 20, 2026 · Form 4 insider transaction
Schoenberg Mark sold 60,677 shares of UroGen Pharma Ltd. at $47.05 per share, a transaction worth $2.85M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
60,677
Price
$47.05
Total value
$2.85M
InsiderSchoenberg Mark
Role—
CompanyUroGen Pharma Ltd. (URGN)
Securityordinary shares
Transaction codeS: Open-market sale
Transaction dateAugust 20, 2026
Filing dateAugust 24, 2026
Shares owned after59,086
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.30 to $49.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.